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Mitochondria are essential to neuronal viability and function due to their roles in
ATP production, intracellular calcium regulation, and activation of apoptotic pathways.
Accordingly, mitochondrial dysfunction has been indicated in a wide variety of
neurodegenerative diseases, including Alzheimer’s disease (AD), Huntington’s disease,
amyotrophic lateral sclerosis, stroke, and multiple sclerosis (MS). Recent evidence points
to the permeability transition pore (PTP) as a key player in mitochondrial dysfunction in
these diseases, in which pathologic opening leads to mitochondrial swelling, rupture,
release of cytochrome c, and neuronal death. Reactive oxygen species (ROS), which are
inducers of PTP opening, have been prominently implicated in the progression of many of
these neurodegenerative diseases. In this context, inactivation of a mitochondria-targeted
redox enzyme p66ShcA (p66) has been recently shown to prevent the neuronal cell
death leading to axonal severing in the murine model of MS, experimental autoimmune
encephalomyelitis (EAE). To further characterize the response of neurons lacking p66,
we assessed their reaction to treatment with stressors implicated in neurodegenerative
pathways. Specifically, p66-knockout (p66-KO) and wild-type (WT) neurons were treated
with hydrogen peroxide (H2O2) and nitric oxide (NO), and assessed for cell viability
and changes in mitochondrial properties, including morphology and ROS production. The
results showed that p66-KO neurons had greater survival following treatment with each
stressor and generated less ROS when compared to WT neurons. Correspondingly,
mitochondria in p66-KO neurons showed diminished morphological changes in response
to these challenges. Overall, these findings highlight the importance of developing
mitochondria-targeted therapeutics for neurodegenerative disorders, and emphasize p66,
mitochondrial ROS, and the PTP as key targets for maintaining mitochondrial and neuronal
integrity.
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INTRODUCTION
The importance of mitochondrial function in the integrity and
stability of neurons and neuronal networks is well established
(Hajnóczky and Hoek, 2007; Rizzuto et al., 2008; Szabadkai and
Duchen, 2008; Duchen and Szabadkai, 2010). In addition to
ATP synthesis to maintain neuronal ion gradients, axonal trans-
port, and all synthetic functions, mitochondria also represent a
repository of prominent regulators of neuronal apoptosis and
an important neuronal Ca2+ store. Not surprisingly then, given
their involvement in key neuronal functions, persistent mito-
chondrial dysfunction has been hypothesized to be important
to the pathogenesis of common neurological disorders including
neurodegenerative conditions such as Alzheimer’s disease (AD),
Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and
multiple sclerosis (MS) (Lu et al., 2000; Mattiazzi et al., 2002;
Damiano et al., 2006; Dutta et al., 2006; Rui et al., 2006; De Vos
et al., 2007; Sasaki and Iwata, 2007; Bueler, 2009; Wang et al.,
2009; Narendra et al., 2010; Kim-Han et al., 2011).
A key mediator of mitochondrial function and dysfunction
in neurons is the permeability transition pore (PTP), which can
pathologically open via inducers such as Ca2+ and reactive oxygen
species (ROS) leading to neuronal death (Bernardi et al., 2006).
Consequently, modification of the pore, in particular through
pharmacological or genetic manipulation of a regulatory compo-
nent cyclophilin D (CyPD), has been shown to provide axonal
protection in murine models of multiple neurodegenerative dis-
eases, including AD, PD, ALS, MS, and stroke (Schinzel et al.,
2005; Forte et al., 2007; Du et al., 2008; Martin et al., 2009; Wang
et al., 2009).
PTP transitions between open and closed states can be reg-
ulated at many levels; consequently, misregulation of these
upstream pathwaysmay lead to persistent, pathological activation
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of the PTP. It has also become clear that ROS are potent
inducers of the PTP through oxidative mechanisms that can
function under both physiological and pathological conditions
(Petronilli et al., 1994; Danial and Korsmeyer, 2004). An intrigu-
ing example of this mode of regulation has recently been
ascribed to p66ShcA (p66), a specific splice variant of the ShcA
gene (Ravichandran, 2001). In contrast to other ShcA isoforms
(p52ShcA and p46ShcA), p66 is not involved in Ras regulation;
rather, p66 contains an atypical mitochondrial targeting sequence
(Migliaccio et al., 1997). Under normal conditions, 40% of p66 is
localized to mitochondria, where it can act as an oxidoreductase
by accepting electrons from reduced cytochrome c. Subsequently,
these electrons are used to reduce molecular oxygen in the gen-
eration of O−2 and then hydrogen peroxide (H2O2), driving PTP
opening (Giorgio et al., 2005; Pinton et al., 2007; Pellegrini and
Baldari, 2009). Indeed, a variety of studies have supported a
model in which a “stress sensing complex” keeps p66 inactive as
long as stress levels remain moderate (Gertz et al., 2009; Gertz
and Steegborn, 2010). However, under conditions of increased
cellular stress, p66 has been proposed to function in a positive
feed-forward loop, whereby ROS stresses lead to increased lev-
els of p66-generated ROS, which ultimately induce cell death
through persistent PTP opening. In such a model, the PTP has
been proposed to constitute the immediate downstream target of
mitochondrial p66 action in the activation of cell death pathways,
a hypothesis that is in keeping with the recent demonstration that
O−2 sparks may be one of the key triggers for PTP opening in situ
(Wang et al., 2008).
Consistent with this model, our previous work has demon-
strated a key role for p66-generated stresses in the propagation
of neurodegenerative disease; genetic inactivation of p66 reduced
the extent of axonal damage in spinal cords and optic nerves
following EAE induction (Su et al., 2012) as did elimination
of CyPD (Forte et al., 2007), establishing a functional interac-
tion between p66 and the PTP on an in vivo level. To further
our understanding of how p66 elimination promotes neuropro-
tection, here we have compared hippocampal neurons lacking
p66 with control, wild-type (WT) neurons in the presence of
challenges implicated in the axonal degeneration responsible for
permanent disability in MS. Specifically, to assess responses to
ROS, neurons were assessed by following treatment of cultures
with H2O2 and to reactive nitrogen species (RNS) following
treatment with DETA-NO. In addition to assessing viability, we
have examined the morphology of mitochondria in response to
these stresses, as previous studies have shown that morphology
changes correlate with eventual neuronal damage under vari-
ous noxious conditions associated with neurodegenerative dis-
eases (Solenski et al., 2002; Nikic et al., 2011). Mitochondria,
which are normally thin and elongated in morphology, become
swollen and fragmented prior to notable structural damage of
axons, and therefore may serve as a key marker of neuronal dis-
tress. Furthermore, increased intracellular production of oxida-
tive agents, in particular, mitochondria-localized ROS, has been
shown to exacerbate neuronal distress in multiple neurodegen-
erative disease models (Fiskum et al., 2003; Scherz-Shouval and
Elazar, 2007). In this report, we demonstrate that neurons lack-
ing p66 exhibit protection in response to oxidative challenges as
well as preservation of mitochondrial morphology and reduction
of mitochondrial ROS production. These results strengthen the
theory that mitochondria-targeted redox enzyme p66 functions
as a direct upstream activator of PTP-mediated neuronal death in
neurodegenerative diseases.
MATERIALS ANDMETHODS
ANIMALS
p66-knockout (p66-KO) mice (kindly provided by Dr. Marco
Giorgio) were maintained as homozygotes in a C57BL/6 back-
ground (Migliaccio et al., 1999). Isogenic WT C57BL/6 mice
were obtained from The Jackson Laboratory (Bar Harbor,
ME). All experimental procedures were conducted following
NIH guidelines under an Institutional Animal Care and Use
Committee-approved protocol from the Oregon Health and
Science University.
PREPARATIONOF POST-NATAL HIPPOCAMPAL NEURONAL CULTURES
Dissected hippocampi of p66-KO andWT post-natal mouse pups
(P0–P2) were incubated for 30–35min at 37◦C in a solution of
2mg/mL papain (Worthington Biochemical Corp., Lakewood,
NJ) in B27/Neurobasal A medium (Invitrogen, Carlsbad, CA)
with 0.5mM glutamine (Sigma, St. Louis, MO, USA). The hip-
pocampi were then transferred into 2mL of culture medium
[B27/Neurobasal A medium with 0.5mM glutamine and 50mg/L
gentamicin (Sigma, St. Louis, MO)] and triturated 10 times with
a 1000 ul pipette tip, followed by 10 times with a 200 ul pipette
tip. Approximately 2mL of the supernatant was transferred into a
new tube, and the remaining tissue was resuspended in another
2mL of medium and triturated as described above. The cells
were counted by hemocytometer and seeded on six well plates
pre-coated with 10μg/mL poly-d-lysine (PDL) (Sigma, St. Louis,
MO) at a density of 100,000 cells/well. After 24 h incubation in
a humidified incubator at 37◦C and 5% CO2, the medium was
replaced with fresh culture medium.
CELL VIABILITY STUDIES
The hippocampal neuronal cultures were maintained for one
week before experimental manipulation. Prior to treatment with
either diethylenetriamine/nitric oxide adduct (DETA-NO) or
H2O2 (Sigma, St. Louis, MO), the cells were washed with
Neurobasal A medium/0.5mM glutamine. Half of the six wells
were designated control wells and incubated with Neurobasal
A medium/0.5mM glutamine. The other wells were designated
treatment wells and incubated with different concentrations of
DETA-NO (100, 250, and 500μM) or H2O2 (100, 250, 500μM,
and 1mM) in Neurobasal A medium/0.5mM glutamine. The
DETA-NO treatments were incubated for 1 h at room temper-
ature to allow for the generation and release of nitric oxide.
Cells treated with H2O2 were incubated for 15min at 37◦C, and
cells treated with DETA-NO were incubated for 3 h at 37◦C.
Following the indicated treatment period, the cells were washed
twice in Neurobasal A medium/0.5mM glutamine and returned
to the incubator in fresh culture medium. Neuronal viability was
assessed 24 h later by incubating the cells in 1μM Calcein AM
(AnaSpec, San Jose, CA) for 30min at 37◦C, andmanually count-
ing live neurons based on morphologic appearance and presence
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of green fluorescent dye at 20X with a fluorescence inverted
microscope. Each well was divided andmarked into eight regions,
and three random areas were counted per region. A total of 72
random areas were counted per treatment or control group per
plate. The cell viability percentage was calculated per plate as
follows: (live cell count in treatment group)/(live cell count in
control group)× 100. All analyseswere done blinded to genotype.
Qualitative images of the cell viability studies were taken with
either a widefield-inverted microscope at 10X or with a Zeiss
LSM710 confocal microscope at 5X.
MITOCHONDRIAL MORPHOLOGY EXPERIMENTS
Post-natal neurons were dissociated from hippocampal tissue as
described above, and 1–2 million cells were pelleted and resus-
pended in 100μL of nucleofection solution with 3μg each of a
plasmid that directs the expression of GFP within the mitochon-
drial matrix (Pinton et al., 2007) and a plasmid that directs the
expression of mCherry in actin as a neuronal filler (mCherry–β-
actin plasmid) (both plasmids generously provided by Dr. Gary
Banker at OHSU). The cell/plasmid solution was electroporated
following the Amaxa electroporation system protocol (Amaxa,
Lonza, Basel, Switzerland) for post-natal neurons using pro-
gram O-05. Following electroporation, the cells were counted
and plated in culture medium at 100,000 cells/well in six well
plates, with each well containing a 25mm glass coverslip coated
overnight with 10μg/mL PDL. After 24 h incubation in a humid-
ified incubator at 37◦C and 5% CO2, the medium was replaced
with fresh culture medium.
Week-old cultures were treated with either the controlmedium
(Neurobasal A medium/0.5 mM glutamine), 25μM H2O2, or
500μM DETA-NO for 1 h at 37◦C. The cells were then washed
twice with Neurobasal A medium/0.5mM glutamine and fixed
with 4% paraformaldehyde for 20min at 37◦C. Following fix-
ation, the cells were washed twice with 1X PBS, and the cov-
erslips were mounted on slides with Prolong Gold Anti-Fade
(Invitrogen, Carlsbad, CA). The slides were imaged with a Zeiss
LSM710 confocal microscope using a 63X oil objective. For each
randomly chosen neuron, a Z-stack of the axon was imaged
(0.38μm sections; 8–10 sections per neurite). Each z-stack was
converted into a 3D image and analyzed by Bitplane Imaris™
software (BitPlane Inc., Saint Paul, MN). To quantify mitochon-
drial morphology changes, mitochondria in each image were
selected by thresholding and analyzed using the Ellipsoid Axis
C parameter. Mitochondrial length was defined as the Ellipsoid
Axis C parameter × 2. All analyses were done blinded to geno-
type.
MITOCHONDRIAL ROS PRODUCTION EXPERIMENTS
Post-natal hippocampal neurons were electroporated with
mitoGFP, and then plated on 25mm PDL-coated glass coverslips
in six well plates as described above. Week old cells were treated
with either the control medium (Neurobasal A medium/0.5mM
glutamine), 25μM H2O2, or 500μM DETA-NO for 1 h at 37◦C.
Afterwards, the cells were washed twice with Neurobasal A
medium/0.5mM glutamine and incubated with 1μM Mitosox
Red, a fluorescent reporter that monitors mitochondrial superox-
ide levels (Invitrogen, Carlsbad, CA) at 37◦C for 10min. The cells
were then washed twice with Neurobasal A/0.5mM glutamine,
fixed with 4% paraformaldehyde for 20min at 37◦C, and washed
twice with 1X PBS. The coverslips were mounted onto slides with
Prolong Gold Anti-Fade.
The slides were imaged with a Zeiss LSM710 confocal micro-
scope using a 63X oil objective. Axons of neurons expressing
mito-GFP were imaged in both red and green channels to cap-
ture mitochondrial GFP expression and corresponding Mitosox
Red staining. Images were analyzed using Metamorph software
(Molecular Devices, Sunnyvale, CA) to acquire average intensity
measurements of randomly selected mitochondria. Between 20
and 30 axonal mitochondria were analyzed per image.
FIGURE 1 | p66-KO neurons are more resistant to H2O2 treatment
compared to WT neurons.Week-old p66-KO and WT hippocampal
neurons were treated with various concentrations of H2O2 (100, 250,
500μM, and 1mM) for 15min. Cell counts were obtained 24h
post-treatment using Calcein AM as a viability indicator. (A) Cell viability
percentages were significantly greater for the p66-KO neurons compared to
the WT neurons for the tested H2O2 concentrations (∗ = p < 0.05).
(B) H2O2 concentration vs. survival percentage curves showed that the
EC50 for 50% survival was approximately 280μM for WT neurons and
680μM for p66-KO neurons, demonstrating that p66 elimination is
associated with increased resistance to H2O2 treatment
(n per treatment/genotype= 3 cultures; 4 plates/culture).
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STATISTICS
All statistical comparisons between the p66-KO and WT groups
were calculated using the Student’s T-test for groups with unequal
variance. Statistical significance was defined as p < 0.05.
RESULTS
p66-KO NEURONS ARE MORE RESISTANT TO OXIDATIVE
CHALLENGES COMPARED TOWT NEURONS
ROS and RNS species generated by activated microglial cells
and immune cells have been proposed to induce mitochon-
drial dysfunction and neurodegeneration in a variety of neu-
rodegenerative diseases, including MS (Ghafourifar et al., 2008;
Su et al., 2009). Therefore, to determine whether p66 elimi-
nation protects neurons from the deleterious effects of these
stressors, p66-KO, and WT neuronal cultures were treated with
physiologic and pathologic levels of H2O2 and NO, and cell
viability was assessed 24 h later (Malinski et al., 1993; Hyslop
et al., 1995; Solenski et al., 2003). Elimination of p66 pro-
moted significant neuroprotection in the p66-KO hippocam-
pal cultures following treatment with varying concentrations
of either NO or H2O2. Specifically, a range of physiologic
and pathologic H2O2 concentrations was analyzed (100, 250,
500μM, and 1mM), and p66-KO cultures showed significantly
greater cell viability compared to WT cultures (Figure 1A).
Based on the concentration vs. survival percentage curves gen-
erated, the H2O2-associated EC50 for 50% survival was approx-
imately 280μM for WT neurons and 680μM for p66-KO
neurons, more than twice the WT concentration (Figure 1B).
Representative images of control WT (Figures 2A,C) and p66-
KO neurons (Figures 2B,D) further document the preservation
FIGURE 2 | p66-KO neurons show greater preservation of neuronal
structure compared to WT neurons following H2O2 treatment.
Representative images of week-old p66-KO and WT neurons at 24h
post-treatment with either control media (A,B) or 500μM 2 2 (C,D); viable
cells have been fluorescently labeled with Calcein AM. Images were taken
with a wide-field inverted fluorescence microscope using a 10X objective.
Note the greater percentage of viable neurons in the p66-KO culture (D)
compared to the WT culture (C) (Bar in A = 50μm).
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of neuronal structure in p66-KO neurons in response to H2O2
challenges.
In addition, p66-KO and WT cell cultures were treated
with different concentrations of the NO donor DETA-NO.
DETA-NO serves as a reliable NO donor since this compound
degrades at physiological pH to release NO with predicable
first order kinetics (Griffiths et al., 2003). According to pre-
vious studies, 1000μM DETA-NO equates to approximately
7μM NO after 4 h of incubation, a concentration that is simi-
lar to NO levels measured with brain microdialysis during brain
ischemia/reperfusion (1–10μM) (Malinski et al., 1993; Solenski
et al., 2003). Therefore, the concentrations of DETA-NO uti-
lized in the cell viability experiments (100–500μM) likely cor-
respond to levels of NO occurring in vivo under physiologic
and pathologic conditions. Similar to the H2O2 results, p66
elimination was found to be associated with significant neu-
roprotection following DETA-NO treatment (Figure 3A). The
DETA-NO-associated EC50 was approximately 220μM for WT
neurons, and beyond experimental treatment concentrations for
the p66-KO neurons (Figure 3B). Representative images of con-
trol WT (Figures 4A,C) and p66-KO neurons (Figures 4B,D) fur-
ther document the preservation of neuronal structure in p66-KO
neurons in response DETA-NO challenges.
Overall, the viability results indicate that p66 elimination in
neurons provides significant protection in response to agents
implicated in neurodegenerative pathways, and furthermore, sup-
port our previous in vivo animal studies (Su et al., 2012).
p66-KO AXONALMITOCHONDRIA SHOW GREATER PRESERVATION
OF MITOCHONDRIAL LENGTH FOLLOWING OXIDATIVE STRESS
Mitochondrial morphology has been associated with axonal dam-
age and oxidative stress in both in vitro and in vivo settings
(Pinton et al., 2007; Nikic et al., 2011). In particular, past stud-
ies on mouse embryonic fibroblasts (MEFs) treated with H2O2
demonstrated that mitochondrial morphology was considerably
preserved with p66 elimination; mitochondria from p66-KO
MEFs treated with H2O2 remained thin and elongated in struc-
ture compared to those of WT MEFs, which were considerably
rounder and shortened (Pinton et al., 2007).
To assess whether mitochondrial morphology changes in
response to H2O2 and NO challenges are minimized in p66-KO
compared to WT neurons, hippocampal cultures were electro-
porated with mito-GFP and mCherry beta-actin plasmids, and
then treated with 25μM H2O2, 500μM DETA-NO, or the con-
trol medium for an hour. Neuronal cultures were subsequently
analyzed for changes in mitochondrial structure. Utilizing Imaris
software, 3D reconstructions of axons were generated from
imaged z-stacks, and mitochondrial length within axons was
assessed by the ellipsoid axis C parameter (Figure 5). In the con-
trol medium-treated neurons, the average mitochondrial length
was similar between the WT and p66-KO neurons (WT 2.10 ±
0.11μm, p66-KO 2.08 ± 0.12μm; p = 0.456). Following treat-
ment with either H2O2 or DETA-NO, both p66-KO and WT
neuronal cultures showed decreases in mitochondrial length, but
the decrease was minimal in mitochondria of p66-KO axons.
In cultures treated with 25μM H2O2, WT mitochondria were
shortened by 0.48 ± 0.03μm compared to 0.19 ± 0.08μm for
FIGURE 3 | p66-KO neurons are more resistant to DETA-NO treatment
compared to WT neurons.Week-old p66-KO and WT hippocampal
neurons were treated with various concentrations of DETA-NO (100, 250,
and 500μM) for 3 h. Cell counts were obtained 24h post-treatment using
Calcein AM as a viability indicator. (A) Cell viability percentages were
significantly greater for the p66-KO neurons compared to the WT neurons
for the tested DETA-NO concentrations. (∗ = p < 0.05). (B) DETA-NO
concentration vs. survival percentage curves showed that the EC50 for
50% survival was approximately 220μM for WT neurons and beyond
experimental treatment concentrations for the p66-KO neurons,
demonstrating that p66 elimination is associated with considerably
increased resistance to DETA-NO treatment (n per treatment/genotype= 3
cultures; 4 plates/culture).
the p66-KO mitochondria (p = 0.008). The resultant WT mito-
chondria had an average length of 1.62 ± 0.03μm compared
to 1.89 ± 0.08μm for the p66-KO mitochondria (p = 0.008).
Similarly, in cultures treated with 500μM DETA-NO, WT mito-
chondria were shortened by 0.31 ± 0.02μm compared to 0.06 ±
0.01μm for the p66-KO mitochondria (p = 0.0001). Following
exposure to DETA-NO, WT mitochondria had an average length
of 1.79 ± 0.02μm compared to 2.02 ± 0.01μm for the p66-KO
mitochondria (p = 0.0002). Overall, the results demonstrated
that axonal mitochondria were significantly shortened follow-
ing oxidative challenges of WT neurons compared to p66-KO
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FIGURE 4 | p66-KO neurons show greater preservation of neuronal
structure compared to WT neurons following DETA-NO treatment.
Representative images of week-old p66-KO and WT neurons at 24h
post-treatment with either control media (A,B) or 500μM DETA-NO (C,D);
viable cells have been fluorescently labeled with Calcein AM. Images were
taken with a laser scanning confocal microscope using a 5X objective. Note
the greater percentage of viable neurons in the p66-KO culture (D) compared
to the WT culture (C) (Bar in A = 50μm).
neurons, suggesting that p66 elimination preserves neurons in
part, by the maintenance of mitochondrial integrity under these
conditions.
p66-KO NEURONS GENERATE LESS ROS FOLLOWING EXPOSURE
TO OXIDATIVE STRESS
To determine whether p66 elimination in neurons impacts mito-
chondrial ROS generation, p66-KO andWT cultures were treated
with control medium or individual agents (25μMH2O2, 500μM
DETA-NO) and then assessed for changes in ROS levels via
Mitosox staining, a fluorescent reporter of mitochondrial super-
oxide production. The results demonstrated that WT neurons
had significantly greater increases in Mitosox intensity levels
compared to p66-KO neurons following oxidative challenges
(Figure 6). Specifically, WT neurons treated with 25μM H2O2
showed a 1.48 ± 0.12X increase in Mitosox intensity compared
to a 1.03 ± 0.03X increase in p66-KO neurons (p = 0.003).
Similarly, WT neurons treated with 500μM DETA-NO showed a
1.37 ± 0.12X increase in Mitosox intensity compared to minimal
change (0.96 ± 0.04X) in p66-KO neurons (p = 0.003). Overall,
these results suggest that ROS levels increase significantly in
WT neurons compared to p66-KO neurons following oxidative
insults.
DISCUSSION
In this report, neurons lacking p66 were demonstrated to be
resistant to ROS and RNS stresses implicated in neurodegenera-
tive pathways. Specifically, greater cell viability was demonstrated
in p66-KO cultures compared to WT cultures at various treat-
ment concentrations of H2O2 and DETA-NO, each of which
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FIGURE 5 | p66-KO axonal mitochondria show greater preservation of
mitochondrial length following oxidative stress. Mitochondrial
morphology changes in week-old p66-KO and WT neurons were compared
following treatment with either 25μM H2O2, 500μM DETA-NO, or control
media for 1 h. Mitochondria were labeled with mito-GFP for visualization
and quantification of morphology changes following treatment. (A) p66-KO
and WT axonal mitochondria were similar in length following treatment with
control media (WT 2.10± 0.11μm, p66-KO 2.08± 0.12μm). Following
treatment with H2O2, axonal mitochondrial length was significantly more
preserved in p66-KO neurons (1.89± 0.08μm) compared to WT neurons
(1.62± 0.03μm). Similarly, following treatment with DETA-NO, axonal
mitochondrial length was significantly more preserved in p66-KO neurons
(2.02± 0.01μm) compared to WT neurons (1.79± 0.02μm).
(B) Quantification of mitochondrial morphology changes following oxidative
challenges demonstrated that p66 elimination in neurons was associated
with significantly less changes in axonal mitochondrial length
(H2O2 = −0.19± 0.08μm; DETA-NO = −0.06± 0.01μm) compared to
WT axonal mitochondria (H2O2 = −0.48± 0.03μm; DETA-NO
= −0.31± 0.02μm). (∗ = p < 0.05) (n = 10 images/treatment/
genotype).
has been demonstrated to drive related apoptotic processes in
neurons (e.g., Tamatani et al., 1998; Mailly et al., 1999; Brune,
2005). To further address the underlying mechanisms associated
with increased cell viability in the p66-KO neurons, changes in
mitochondrial morphology and ROS production were charac-
terized following treatment. The results showed that changes in
FIGURE 6 | p66-KO neurons generate less ROS following exposure to
oxidative stress. Week-old p66-KO and WT neurons were treated with
either 25μM H2O2, 500μM DETA-NO, or control media for 1 h, and
assessed for changes in mitochondrial ROS levels. Mitochondria were
visualized with mito-GFP labeling, and mitochondrial ROS was visualized
following Mitosox (a fluorescent reporter of mitochondrial superoxide)
incubation. Following H2O2 treatment, p66-KO neurons showed
significantly less increases in mitochondrial ROS levels compared to WT
neurons (p66-KO = 1.03± 0.03X; WT = 1.48± 0.12X). Similarly, following
DETA-NO treatment, p66-KO neurons showed significantly less increases in
mitochondrial ROS levels compared to WT neurons (p66-KO =
0.96± 0.04X; WT = 1.37± 0.12X). (∗ = p < 0.05) (n = 10
images/treatment/genotype).
mitochondrial morphology were less prominent in the p66-KO
neurons compared to the WT neurons, with significantly greater
preservation of mitochondrial length. In addition, the p66-KO
neurons exhibited less elevated mitochondrial ROS levels com-
pared to WT neurons following oxidative insults. Overall, these
findings suggest that p66 elimination incurs greater neuronal
robustness and preservation of mitochondrial integrity following
oxidative insults implicated in neurodegenerative mechanisms.
Importantly, these findings support our current understand-
ing of p66 and its role in cellular responses to oxidative challenges.
As outlined earlier, p66 is thought to serve as a ROS sensor
and amplifier under conditions of cellular stress by amplifying
ROS generation via cytochrome c oxidation and oxygen reduc-
tion (Giorgio et al., 2005). Subsequently, elevated ROS has been
shown to induce PTP opening as demonstrated by mitochondrial
swelling, rupture, and release of cytochrome c to activate apop-
totic pathways (Petronilli et al., 1994; Vercesi et al., 1997; Yang
et al., 2007). The results reported here are consistent with this pro-
posed pathway, as shown by the higher ROS levels inWT neurons
compared to p66-KO neurons following stresses induced by H2O2
or DETA-NO treatment, demonstrating that p66 elimination
reduces ROS amplification following these insults. This, in turn,
provides greater preservation of mitochondrial integrity as visual-
ized by mitochondrial morphology. Previous studies have corre-
lated changes in mitochondrial morphology with mitochondrial
integrity and activity, including the balance of fission and fusion
events and mitophagy of damaged mitochondria. In particular,
it has been shown that the dissipation of the mitochondrial
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membrane potential affects fusion and induces mitochondrial
fragmentation (Legros et al., 2002). Furthermore, mitochon-
drial morphology changes may be correlated to matrix swelling
mediated by pathologic PTP opening, release of cytochrome c,
and activation of cell death pathways (Scorrano et al., 2002).
Assuming that p66 elimination alters the cell crisis signal of
elevated mitochondrial ROS, preserves mitochondrial integrity,
and subsequently regulates PTP-mediated cell death, this would
suggest greater neuronal robustness in p66-KO neurons fol-
lowing these stresses, as is supported by our cell viability
studies.
Overall, the characterization of p66 elimination in neurons
supports previous studies demonstrating mitochondrial integrity
as a key marker of neuronal viability and fate (Nikic et al., 2011).
Hence, therapeutics promoting mitochondrial preservation may
prove essential to current treatment regimens for neurodegener-
ative diseases. Mitochondria-targeted drugs are currently being
developed, utilizing lipophilic cations or peptides to deliver drug
directly to the negatively charged mitochondrial matrix (Sheu
et al., 2006; Murphy, 2008). Furthermore, drugs are being devel-
oped for specific mitochondrial components such as the PTP
via cyclosporin A derivatives targeting the regulatory component
CyPD, and ROS via antioxidants such as MitoQ and SS-peptides
(Tauskela, 2007; Rocha et al., 2010). The results reported here
suggest that pharmacologic inhibition of p66 may also provide
neuroprotection by the aforementioned mechanisms, and corre-
spondingly, the results from the in vivo studies have demonstrated
potential physiologic protection associated with p66 elimination
in the context of EAE (Su et al., 2012), MS, and additional
neurodegenerative conditions.
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